PTC Therapeutics, Inc. (PTCT) Free cash flow 2016–2025
PTC Therapeutics, Inc. (PTCT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$702.3MFY2025 · since FY2016: -$105.3M → $702.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $702.3M | +715.1% |
| FY2024 | -$114.2M | +38.9% |
| FY2023 | -$186.9M | +51.9% |
| FY2022 | -$388.7M | -39.0% |
| FY2021 | -$279.5M | -31.9% |
| FY2020 | -$211.9M | -88.5% |
| FY2019 | -$112.4M | -223.6% |
| FY2018 | -$34.7M | -163.9% |
| FY2017 | -$13.2M | +87.5% |
| FY2016 | -$105.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice